Sage Journals: Discover world-class research

Open access

Research article

First published 2011-4

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

Magnhild Sandberg-Wollheim, Enrica Alteri, Margaretha Stam Moraga [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2011-4

The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-1a: analysis of data from clinical trial and post-marketing surveillance settings

Magnhild Sandberg-Wollheim, Gabrielle Kornmann, Dorina Bischof [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2018-2

Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection

Giancarlo Coghe, Laura Atzori, Jessica Frau [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2018-2

Commentary on “Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection” by Coghe et al.

Bernadette Porter

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-9

Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis

Rafael Arroyo González, Mariko Kita, Heidi Crayton [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2014-5

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised,controlled phase 3 trial

Patrick Vermersch, Anna Czlonkowska, Luigi ME Grimaldi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2011-8

Quality of life,depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

F Patti, MP Amato, M Trojano [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2010-01

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

F. Patti, MP Amato, S. Bastianello [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2013-7

Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis

Silvia N. Tenembaum, Brenda Banwell, Daniela Pohl [...]

Journal of Child Neurology

Free access

Other

First published 2009-03

Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study

Francesco Patti, Maria Pia Amato, Stefano Bastianello [...]

Therapeutic Advances in Neurological Disorders

Search results